GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » 5-Year Dividend Growth Rate

Valiant Laboratories (BOM:543998) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories 5-Year Dividend Growth Rate?

Valiant Laboratories's Dividends per Share for the three months ended in Dec. 2024 was ₹0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Valiant Laboratories's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Valiant Laboratories's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Valiant Laboratories's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valiant Laboratories's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Valiant Laboratories's 5-Year Dividend Growth Rate falls into.


;
;

Valiant Laboratories 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Valiant Laboratories  (BOM:543998) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Valiant Laboratories's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ 0.54
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valiant Laboratories 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Valiant Laboratories Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines